HEPATITIS EDUCATION PROJECT

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1994

Legal Domicile

Principal Officer

APOORVA MALLYA

Phone

2067320311

Tax Period

2023-01-01 to 2023-12-31

HEPATITIS EDUCATION PROJECT, founded in 1994, is a community nonprofit in the Education sector that reported $2.6M in total revenue in fiscal year 2023. Revenue grew 19% year-over-year, indicating healthy expansion.

Mission

THE HEPATITIS EDUCATION PROJECT IS COMMITTED TO PROVIDING SUPPORT, EDUCATION, ADVOCACY AND DIRECT SERVICES FOR PEOPLE AFFECTED BY HEPATITIS AND TO HELPING RAISE HEPATITIS AWARENESS AMONG PATIENTS, MEDICAL PROVIDERS AND THE GENERAL PUBLIC.

Program Service Accomplishments

Program 1

Expenses: $845,296 Revenue: $80,100

VIRAL HEPATITIS EDUCATION, TESTING, LINKAGE TO CARE, AND CORRECTIONAL HEALTH: HEP PROVIDES EDUCATION TO CLIENTS, PROVIDERS, AND ORGANIZATIONS, FREE HEPATITIS C AND B TESTING, LINKAGE TO CARE, AND...

VIRAL HEPATITIS EDUCATION, TESTING, LINKAGE TO CARE, AND CORRECTIONAL HEALTH: HEP PROVIDES EDUCATION TO CLIENTS, PROVIDERS, AND ORGANIZATIONS, FREE HEPATITIS C AND B TESTING, LINKAGE TO CARE, AND FREE HEPATITIS A/B VACCINATION. IN 2023, HEP PROVIDED 464 HCV AB TESTS, 90 HCV RNA TESTS, AND 83 HBV TESTS. HEP ALSO FACILITATES CLASSES ON HEPATITIS, BLOODBORNE PATHOGENS, AND HARM REDUCTION FOR PRISONS AND JAILS THROUGHOUT WASHINGTON STATE. HEP'S CORRECTIONAL HEALTH PROGRAM CONTINUED WITH MAIL-IN CORRESPONDENCE COURSEWORK DUE TO PANDEMIC IN-PERSON RESTRICTIONS IN CORRECTIONAL FACILITIES. IN-PERSON CLASSES RETURN IN 2024.

Program 2

Expenses: $741,770 Revenue: $42,938

DRUG USER HEALTH: HEP RUNS A SYRINGE SERVICE PROGRAM (SSP) AND PARTNERS WITH A LOCAL FQHC TO PROVIDE MEDICATIONS FOR OPIOID USE DISORDER TREATMENT (MOUD) LOCATED IN THE HEP OFFICE. HEP CONTINUES TO WORK WITH ENCAMPMENTS TO PROVIDE HARM REDUCTION AND LINAGE TO CARE SERVICES. IN 2023 HEP DISTRIBUTED 255,383 STERILE SYRINGES THROUGH SSP AND 8542 DOSES OF NALOXONE, AN OPIOID-OVERDOSE REVERSAL MEDICATION. HEP HAD 47 MOUD INDUCTIONS IN 2023.

Program 3

Expenses: $512,380 Revenue: $0

NATIONAL, STATE, AND LOCAL POLICY AND ADVOCACY: HEP MANAGES THE NATIONAL HEPATITIS CORRECTIONS NETWORK (NHCN) AND THE NATIONAL VIRAL HEPATITIS ROUNDTABLE (NVHR). THE NETWORKS ARE NATIONAL COALITIONS OF MEDICAL PROVIDERS, ADMINISTRATORS, RESEARCHERS, COMMUNITY-BASED ORGANIZATIONS, AND OTHER PUBLIC HEALTH ADVOCATES WORKING TOGETHER TO INCREASE ACCESS TO HEPATITIS PREVENTION, TESTING AND TREATMENT IN CORRECTIONAL FACILITIES, AND TO ELIMINATE VIRAL HEPATITIS IN THE UNITED STATES. IN 2023, NVHR STRENGTHENED OUR NATIONAL COALITION AND STRATEGIC PARTNERSHIPS, HELPED LEAD THE VIRAL HEPATITIS COMMUNITY IN ELMINATION ADVOCACY EFFORTS, AND EXPANDED THE REACH OF OUR GRASSROOTS ADVOCACY NETWORK.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,527,014

Program Service Revenue $123,038

Investment Income $17,435

Other Revenue $-31,697

TOTAL REVENUE $2,635,790

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,700,976

Fundraising Expenses $8,296

Program Expenses $2,099,446

Other Expenses $899,692

TOTAL EXPENSES $2,600,668

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,635,790	$2,224,050	+0.2%
Expenses	$2,600,668	$2,882,590	-0.1%
Net Income	$35,122	$-658,540	-1.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$206,252

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARIA CORCORRAN MD	PRESIDENT	0.50	Officer Director	$0	$0	$0
JEFFREY KING CPA	TREASURER	0.50	Officer Director	$0	$0	$0
JUDITH TSUI	SECRETARY	0.50	Officer Director	$0	$0	$0
KIM MILLER	DIRECTOR	0.50	Director	$0	$0	$0
ENA ORU	DIRECTOR	0.50	Director	$0	$0	$0
ELSA TAMRU	DIRECTOR	0.05	Director	$0	$0	$0
AMBER CASEY	INTERIM DEPUTY EXECUTIVE DIRECTOR (9/8/22-8/2	40.00	Officer	$84,428	$24,023	$108,451
APOORVA MALLYA	EXECUTIVE DIRECTOR	40.00	Officer	$87,985	$9,816	$97,801

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,635,790	$2,600,668	$1,880,992	$35,122
2022	$2,224,050	$2,882,590	$1,716,112	$-658,540
2021	$1,984,440	$2,579,167	$2,378,469	$-594,727
2020	$2,799,207	$2,184,049	$2,856,929	$615,158
2019	$2,421,967	$1,950,575	$1,739,151	$471,392
2018	$1,435,174	$1,323,510	$1,265,858	$111,664